Medis is proud to actively support the prospective PIONEER-IV Study

The Medis QFR® software is being used in all the centers that are participating in the PIONEER-IV Study with P.I. by Prof. Serruys at the Galway University in IrelandCurrently a total of 16 sites are active from Ireland, the UK, the Netherlands, Belgium and Spain, with more sites to be activated soon.

The PIONEER-IV is a prospective, single-blind (patient), randomized, 1:1, controlled, multi-center study comparing clinical outcomes between angiography-derived physiology guidance (QFR®)  to local routine diagnostic procedure (LRDP) and usual care in an all-comers patient population undergoing PCI with unrestrictive use of the Sinomed HT SUPREME™ sirolimus-eluting stent. 

For the latest updates, please refer to the website of CORRIB Corelab (

We wish the Pioneer-IV team and participants much success and look forward to the future results!

Share this article on:


Sign up for our newsletter

Subscribe now to find out more about our solutions, latest publications and future releases.

By providing your information and continuing, you agree to Medis’ Terms of Use and Privacy Policy *